Drug intelligence / Profile preview

1,10-phenanthroline

Development stage
Unknown
Modality
Small Molecules
01

Overview

1,10‑Phenanthroline is a synthetic heterocyclic organic compound with the formula C₁₂H₈N₂. It is a white to light yellow crystalline powder at room temperature and is moderately soluble in water and various organic solvents[3][6]. The molecule features two nitrogen atoms at the 1 and 10 positions of a three-ringed aromatic system. It acts as a bidentate ligand in coordination chemistry, forming stable colored complexes with many metal ions—most notably iron(II), where it forms the red complex ferroin[2][5]. In biochemistry and pharmacology research, it serves as an inhibitor of metallopeptidases (notably carboxypeptidase A) by chelating essential metal ions such as zinc from enzyme active sites[1][8]. It also inhibits deubiquitination enzymes like Rpn11[2], displays antimicrobial activity[3][5], can prevent chromosomal aberrations induced by certain chemicals[6], and has been studied for potential anticancer properties through its DNA cleavage activity when complexed with metals[7]. While widely used as an analytical reagent for metal ion detection and quantification due to its colorimetric properties, it is not approved or marketed as a pharmaceutical drug for any disease indication in humans[4].

Other names
o-Phenanthrolineortho-phenantrolineβ-phenantroline4,5-diazaphenanthrene4,5-phenantroline1,10-o-phenantrolinephenanthrolinephen (abbreviation)
02

Targets

PSMD14 (Proteasome 26S subunit non-ATPase 14)DUB (Deubiquitinases)

Beyond the preview

Go deeper on 1,10-phenanthroline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1,10-phenanthroline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call